IPOs: The narrow window closes?

Article Abstract:

The amount of money raised by the various biotech firms through the initial public offerings (IPOs) in the United States markets has reduced considerably towards the end of 2004, thus making the biotechnology IPO market appear less attractive. The decrease in the amount of money raised by biotechnology firms through IPOs is attributed to the lack of enthusiasm for the biotech IPO markets, and as no IPOs were filed by the biotech companies during the fourth quarter.

Patents & copyrights, Labor Distribution by Employer, Statistics, Intellectual property, Going public (Securities), Initial public offerings, Company public offering

---

Amgen's TPO mimic faces stiff competition

Article Abstract:

Amgen's phase 3-platelet growth factor candidate to treat blood disorders will face a stiff competition in the market from several small molecules with much better pharmacologic properties, which are in pipeline. There are half a dozen small-molecule and small-protein platelet -stimulating agent projects at various stages of clinical development to treat diseases marked by platelet deficiency.

Product development, Product introduction, New Products/Services, Drug therapy, Blood diseases, Hematologic diseases, Platelet activating factor, Amgen Biologicals/Diagnostics

---

Stock options could no longer be the carrot

Article Abstract:

Stock options were regarded as one of the main incentives to attract the top managers into biotech companies. This will be soon hampered by new legislation issued in mid December 2004 by the Financial Accounting Standards Board (FASB) that requires employee stock option compensation to be treated as an expense, a practice that is closer to most accounting standards in Europe.

United States, Personnel administration, Usage, Human resource management, Company personnel management, Employee stock options

Similar abstracts:

• Abstracts: The art of persuasion. And so to the future. Twists and u-turns
• Abstracts: Chinese biotech: The need for innovation and higher standards. Ask the experts: how to get hired
• Abstracts: Obering: MDA has earned raise. U.S. could cut DOD by half -- analyst. Rudman: First responders need more money
• Abstracts: Large market shocks and abnormal closed-end-fund price behaviour. An analysis of intraday patterns in price clustering on the Tokyo Stock Exchange
• Abstracts: Research issues in building brand equity and global brands in the pc market. Internationalization of services brands: the role of leadership during the internal brand building process

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.